Citadel Advisors
DRTSW icon

Citadel Advisors’s Alpha Tau Medical Warrant DRTSW Stock Holding History

Citadel Advisors’s Portfolio DRTSW Stock Details DRTSW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-33,043
Closed -$7.27K – 13024
2025
Q2 		$7.27K Sell
33,043
-7,650
-19% -$1.7K ﹤0.01% 12216
2025
Q1 		$9.67K Buy
+40,693
New +$12.1K ﹤0.01% 13584
2023
Q3 		– Sell
-22,506
Closed -$8.89K – 14456
2023
Q2 		$8.89K Buy
+22,506
New +$6.87K ﹤0.01% 13287
2023
Q1 		– Sell
-14,226
Closed -$3.56K – 14860
2022
Q4 		$3.56K Sell
14,226
-40,243
-74% -$12.3K ﹤0.01% 14195
2022
Q3 		$23K Sell
54,469
-113
-0.2% -$67 ﹤0.01% 12019
2022
Q2 		$28K Buy
54,582
+396
+0.7% +$221 ﹤0.01% 12260
2022
Q1 		$33K Buy
+54,186
New +$29.6K ﹤0.01% 13050

Other funds holding DRTSW

FFM
Fisher Funds Management Auckland, New Zealand $3.52B AUM 17.59% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return
CPIG
Chicago Partners Investment Group Chicago, Illinois $5B AUM 26.84% 1-Year Est. Return
MCM
Moore Capital Management New York $6.74B AUM 45.87% 1-Year Est. Return
VB
Value Base Tel Aviv, Israel $162M AUM 2.31% 1-Year Est. Return
TCM
Tenor Capital Management New York $7.09B AUM 3.55% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $7.65B AUM 13.87% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $95.2B AUM 32.92% 1-Year Est. Return

Citadel Advisors's DRTSW Position: Q3 2025 in Review

Citadel Advisors sold out of Alpha Tau Medical Warrant (DRTSW) in Q3 2025, closing a stake of 33,043 shares — an estimated $7.27K sold.

Citadel Advisors first reported a position in DRTSW in Q1 2022 and held it in 7 quarters. The position peaked at $33K in Q1 2022. 20 funds tracked by Wall St. Rank hold DRTSW as of Q3 2025.

  • Citadel Advisors reported no remaining Alpha Tau Medical Warrant position as of Q3 2025 after selling out during the quarter.
  • Citadel Advisors sold 33,043 Alpha Tau Medical Warrant shares in Q3 2025, an estimated $7.27K.
  • Citadel Advisors first reported a position in Alpha Tau Medical Warrant in Q1 2022 and held it in 7 quarters.
  • Citadel Advisors's Alpha Tau Medical Warrant position peaked at $33K in Q1 2022.
  • 20 funds tracked by Wall St. Rank held Alpha Tau Medical Warrant as of Q3 2025.

Based on Citadel Advisors's 13F filing for Q3 2025, filed 14 Nov 2025.